2025 Sponsors

From advanced wound care through surgery and sports medicine, we are committed to empowering healing by confidently and reliably delivering clinicians the range of regenerative tissue innovations along with the services they need.

Designed for the management of chronic and acute wounds, our portfolio of advanced wound care solutions can support patients from early in the wound healing process through to wound closure—regardless of wound type.

At Extremity Care we offer a diverse portfolio of cell and tissue products - including placental allografts, xenografts, acellular dermis, and conservative wound care products.

We focus on technologies that support the repair, reconstruction, replacement, or supplementation of the patient’s own tissue. Through our dedicated lab and AATB accredited tissue bank we are at the forefront of cell and tissue engineering. We strive to be good stewards of the precious gift of tissue donation.

With our careLOG™ shipping logistics process, we provide just-in-time handling of cell and tissue products. careLOG™ contains the tissue, product information and the billing-related documents needed to request reimbursement.

Surgeons and scientists founded Imbed Biosciences to create breakthrough wound care technologies to positively impact the lives of patients with acute, chronic and traumatic wounds. Imbed is committed to bringing the most advanced wound care solutions to clinics and hospitals nationwide.

.

Founded in 2019 and headquartered in Carlisle, PA, Advanced Solution LLC leads the way in regenerative medicine and wound care distribution. Committed to innovation and excellence, the company empowers healthcare providers with turnkey solutions that optimize patient outcomes while maximizing revenue generation. Its flagship programs that offer premium biological products supported by prompt delivery, personalized implementation, and comprehensive clinical tools.

Through its proprietary "Tissue Vault" software and FDA-registered Tissue Bank, Advanced Solution streamlines benefit verification, ordering, and logistics, setting the standard for efficiency and reliability. With an unwavering focus on compliance, innovation, and compassion, the company has achieved significant milestones, including the development of cutting-edge logistics infrastructure and the publication of Got Wounds? Wound Care Essentials 101, a cornerstone resource for advanced wound care techniques.

Whether serving private practices, government facilities, or hospital systems, Advanced Solution remains a trusted partner dedicated to transforming healthcare delivery. By integrating advanced technologies and expert-driven strategies, the company ensures exceptional outcomes for providers and patients alike.

Convatec has the first and only FDA-cleared placental medical devices for chronic wounds, surgical wounds, and burns with its innovative InnovaMatrix® technology platform -- now available in powder form and a variety of membrane sizes. For more information, visit www.innovamatrix.com.

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. Alongside our customers we will not settle until we have solved the challenges of preventing and healing wounds, because they hold back too many lives.

Check our their website HERE

.

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular-therapy and regenerative-medicine markets. The fatty-acid-rich products from the company’s patented technologies protect the body’s own tissues and enable the body to regenerate tissues. Developed and manufactured in Isafjordur, Iceland, Kerecis medical products are authorized for sale in Europe, the United States. and several other jurisdictions for human-tissue repair. Thousands of patients are treated annually with our technology. And we are broadening our product line to address many more types of soft-tissue damage.

.

At 180 Health Services, we are committed to being your trusted partner in advanced medical solutions. Our mission is to deliver cutting edge, life-enhancing wound care products to providers throughout the country. We take pride in our extensive range of innovative skin graft biologics for the treatment of non-healing wounds.

Headquartered in Auckland, New Zealand, Aroa Biosurgery is a global medical device company committed to unlocking regenerative healing for everybody through its patented AROA ECM™ complex wound and tissue reconstruction products.

The company was founded in 2008 by Veterinarian Surgeon Dr Brian Ward, who discovered that a tissue scaffold called the extra cellular matrix (ECM) found in the forestomach of sheep has a similar structure to human tissue and contains over 150 proteins known to be important in the healing process.

Aroa Biosurgery has established USA operations, regulatory approval in over 50 countries and employs over 270 people across New Zealand and North America. To date, more than 6 million AROA ECM™ devices have been used in treating patients worldwide.

Athelas — now combined with Commure, Augmedix and Rx.Health — is on a mission to make health the focus of healthcare once again by using AI and automation to eliminate distractions and keep providers connected to their patients throughout the care journey.

Athelas offers a suite of hardware, software, and services that improve patient engagement through intelligent care coordination, reduce provider burnout through workflow automation, enable at-home patient monitoring, reimagine the billing process, and mitigate the threat of workplace violence. Together, these solutions result in happier and healthier patients, less time wasted on administrative tasks, safer staff, and better financial stability for practices and health systems.

Today, we support millions of patient interactions every year, billions of healthcare revenue on our system annually, and over 400,000 clinicians and healthcare workers across hundreds of care sites around the nation.

BioLab Sciences is a leading provider of human tissue products for wound care, committed to the highest standards of quality and safety. FDA-compliant and focused on innovation, we develop advanced tissue solutions to improve patient outcomes. With a dedication to regulatory excellence, we ensure our products meet the strictest guidelines for safety and efficacy in the healthcare industry.

For more information, visit www.biolabholdings.net.

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method. BioREtain® has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes AmnioWrap2™, VENDAJE®, VENDAJE AC®, and VENDAJE OPTIC®. Each BioStem Technologies placental allograft is processed at the Company's FDA-registered and AATB-accredited site in Pompano Beach, Florida.

At Cellution Biologics, we are a trusted partner in advanced human tissue-based products, driven by a commitment to innovation and a legacy of excellence in placental tissue banking. Leveraging our extensive expertise in tissue processing, we deliver transformative solutions that foster a healthier future.

ETS, headquartered in Rolla, Missouri, USA, specializes in developing medical products utilizing proprietary borate-based bioactive glass. Our flagship product, Mirragen®, represents a breakthrough in wound care technology as the first FDA-cleared inorganic bioactive glass-based solution. Mirragen® is a borate-based bioactive glass fiber matrix that facilitates quality tissue formation, without the risk of infection that tissue-based products have, all in an easy to use, versatile form factor.

GR Consulting, LLC is a small boutique consulting and advisory firm that specializes in the wound care and surgical wound care markets. GRc focuses on start-up and early-stage companies who need additional bandwidth to support their expanding business. We are a small team of senior leaders who provide support in strategy, geographic expansion, market access/reimbursement, health economics & outcomes research, regulatory, clinical trial design/execution, and strategic partner searches. Our team has more than 125 years of combined senior level experience and provides the leadership firepower, technical ingenuity, a strong industry network and the expertise to help execute the correct business strategy at the right time. Finally, our business model is set-up to deliver a customized approach to each client’s specific business needs without the bloated overhead and generalist approach that most mid-sized or large consulting firms provide.

Kent Imaging, a leading innovator in tissue oxygenation assessment, designs and manufactures imaging technology that supports realtime decision-making in wound care, vascular and surgical specialties. Unlike some devices that only measure the macrovasculature, SnapshotNIR utilizes near-infrared light to go below the surface and measure tissue oxygen saturation, oxyhemoglobin, deoxyhemoglobin and total hemoglobin in the microvascular network. Use actionable data to document medical necessity, expedite vascular assessment, design treatment plans, and track and document therapeutic efficacy.

Legacy Medical Consultants is an innovative healthcare company elevating advanced wound care with a broad portfolio of human placental allografts, addressing the unmet clinical needs in wound patients. Legacy Medical Consultants’ team of dedicated professionals are here to serve both providers and their patients in the field of complex wound care. Allografts are restricted to use by, or on the order of, a licensed healthcare professional. To learn more about LMC’s portfolio of products please visit https://www.legacymedicalconsultants.com/.

MIMEDX is a transformational placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental tissue engineering, we have both a commercial business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. For additional information, please visit www.mimedx.com.

The MIMOSA Pro consists of a pocket-sized imaging device and a HIPAA-compliant web portal that streamlines tissue health assessments by capturing temperature, tissue oxygenation, and digital images in less than one second. The images automatically upload to the web portal where clinicians can monitor patient progress and collaborate towards improved outcomes.

The MolecuLight i:X® and DX™ point-of-care imaging devices enable detection of elevated bacterial loads and accurate digital wound measurement. They facilitate proactive wound care & inform clinician decision-making in real-time including enabling guided cleaning & debridement. US reimbursement pathway is enabled, along with 80+ peer-reviewed publications.

Net Health’s wound software is built by wound care technology experts with deep domain experience. The difference is the design: a foundation of high-quality, differentiated wound data informs organizational insights and powers predictive analytics. The result is wound care software solutions that improves patient outcomes, streamlines operations, and optimizes ROI.

New Horizon Medical Solutions' dedication to patient care sets us apart and drives us to bring high-quality and effective products to healthcare practices across the nation. We are a leading medical device company specializing in biologics and durable medical equipment (DME). Our network includes a diverse range of medical fields, such as orthopedic surgery, podiatry, wound care, dermatology, spine, and neurosurgery. Known for our commitment to innovation and excellence, New Horizon Medical Solutions strives to provide top-tier medical products that enhance patient care and improve outcomes.

ProMed Billing Solutions recognizes the importance of prompt and accurate billing services. We are committed to providing our clients with services that are quicker and more effective than their current processes. Our dedicated staff has over 20 years of industry knowledge, experience, and are savvy in WoundCare billing and collections. 

RedDress is dedicated to developing revolutionary, biologic advanced wound care solutions based on its patented whole blood technology to recreate the body’s natural healing processes. ActiGraftPRO from RedDress is an innovative autologous point-of-care wound management solution that harnesses your patient's own blood. Once applied, the whole blood clot serves as a protective covering and optimizes the body's own healing potential.

For more information, visit www.reddressmedical.com.

Reprise Biomedical is focused on the development and commercialization of biological medical devices that offer advanced solutions for wound healing. In 2019, Reprise took ownership of two products, under a proprietary perfusion decellularization technology license from the University of Minnesota, MiroDerm biologic wound matrix for advanced wound management and MiroFlex biologic matrix for soft tissue reinforcement. Reprise is committed to delivering novel solutions which address unmet surgical needs for advanced wound care. Our transformational, Miro3D wound matrix, is an example of that commitment. Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunnelling wounds.

Committed to excellence in wound care, RestorixHealth is the wound care solutions company providing programs, services, products and education across the care continuum. From developing and operating wound centers in partnership with hospitals, through delivering professional wound care in nursing facilities and in-home settings, to supporting patients through the coordination of wound supplies, RestorixHealth’s solutions increase access to care, reduce hospital admissions and most importantly, improve patient outcomes and quality of life.

Royal Wound-X is a pioneering leader in wound care research and development, committed to delivering top-tier, innovative biologic solutions that enhance the healing process and improve patients' quality of life. Recognized for its focus on advanced wound care, Royal Wound-X places patient well-being at the center of its mission, offering an exceptional standard of care to address a variety of complex wound and tissue repair needs. At Royal Wound-X, our mission is driven by patient-centered care, innovation and excellence, and integrity and compassion. Royal Wound-X provides a comprehensive array of products tailored to meet the varied needs of the wound care industry, including amniotic, dermal, collagen, synthetic, and platelet-rich fibrin matrix (PRFM) products. As a rapidly expanding force in the industry, Royal Wound-X is continuously developing and launching new products and solutions that set benchmarks for quality, effectiveness, and patient outcomes. Royal Wound-X’s commitment to research and innovation keeps it at the forefront of wound care, helping shape the future of healthcare and improving lives globally.

Samaritan Biologics is a Tennessee based, minority owned small business located in Memphis with R&D and future manufacturing facilities based in Greenville South Carolina on the campus of Clemson University. Samaritan was bootstrapped by 3 founders in 2019 and has no outside investment or physician ownership. Our focus is the development and commercialization of human perinatal tissue allografts to enable doctors to more effectively treat patients for a wide variety of clinical goals including: Limb Preservation, Wound Care, Robotic Oncology, Neurosurgery, Urology, Sports Medicine and Orthopedics. We pride ourselves on taking a scientific approach to perinatal tissues. We live our tagline everyday – Helping, Healing, Giving

SerenaGroup® is a global health care company with the mission of developing the world’s leading Comprehensive Wound Care and Research Centers. They are dedicated to advancing the science of wound healing by utilizing advanced modalities that lead to a positive patient experience and quality outcomes. The focus of SerenaGroup® is on the science as well as establishing a positive financial enterprise.

Stability Biologics is an innovative, regenerative medicine company, providing a full line of advanced biologic products to enhance the lives of patients and create greater surgeon satisfaction. ​

Established in 2009, Venture Medical has pioneered novel solutions in wound care including biofilm management, imaging, diagnostics, and biologic allografts, while expanding access to therapies in multiple care environments. Since its beginning as a small group in the Northwest, Venture Medical has grown to manage sales representation across the US, expanded research in real world settings, and initiated new business models that enable innovative manufacturers to focus on product development and improvements.